Śmigielska Paulina, Czarny Justyna, Kowalski Jacek, Wilkowska Aleksandra, Nowicki Roman J
Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, Gdańsk, Poland.
Department of Pathomorphology, Medical University of Gdańsk, Gdańsk, Poland.
J Scleroderma Relat Disord. 2021 Jun;6(2):211-213. doi: 10.1177/23971983211004399. Epub 2021 Mar 26.
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.
嗜酸性筋膜炎是一种病因不明的罕见结缔组织病。治疗选择包括大剂量皮质类固醇和其他免疫抑制药物。我们报告了一例典型的嗜酸性筋膜炎病例，该病例对一线治疗无反应，但在使用英夫利昔单抗后有显著改善。本报告表明，在初始治疗失败的情况下，英夫利昔单抗可能是一种相对安全有效的嗜酸性筋膜炎治疗方法。
